|
Muscular Disorders, Atrophic
|
|
|
|
89 genes has been reported with Muscular Disorders, Atrophic
|
[Click  to re-sort the table]
|
|
|
|
Meta-analysis Publication
|
DMD
|
41
|
0
|
| DMPK
|
23
|
0
|
| CAPN3
|
8
|
0
|
| SPP1
|
7
|
0
|
| LTBP4
|
6
|
0
|
| DM1
|
5
|
0
|
| AR
|
4
|
0
|
| POMT2
|
3
|
0
|
| DYSF
|
3
|
0
|
| POMT1
|
3
|
0
|
| CNBP
|
3
|
0
|
| ANO5
|
3
|
0
|
| SGCG
|
3
|
0
|
| FKRP
|
3
|
0
|
| TCF4
|
2
|
0
|
| COL8A2
|
2
|
0
|
| FCMD
|
2
|
0
|
| GNE
|
2
|
0
|
| SGCA
|
2
|
0
|
| MBNL1
|
2
|
0
|
| DUX4
|
2
|
0
|
| FKTN
|
2
|
0
|
| ATXN1
|
2
|
0
|
| LARGE
|
2
|
0
|
| TGFB1
|
2
|
0
|
| POMGNT1
|
2
|
0
|
| TRIM11
|
1
|
0
|
| MMD2
|
1
|
0
|
| HTT
|
1
|
0
|
| HLA-B
|
1
|
0
|
| TRNL1
|
1
|
0
|
| C9orf72
|
1
|
0
|
| TGFA
|
1
|
0
|
| TIA1
|
1
|
0
|
| ATXN3
|
1
|
0
|
| DUX4
|
1
|
0
|
| NEURL2
|
1
|
0
|
| FSHMD1A
|
1
|
0
|
| HD
|
1
|
0
|
| GDAP1
|
1
|
0
|
| MYOZ1
|
1
|
0
|
| ATN1
|
1
|
0
|
| FCGR2A
|
1
|
0
|
| FHL1
|
1
|
0
|
| FRAXA
|
1
|
0
|
| FLNC
|
1
|
0
|
| GJB1
|
1
|
0
|
| ISL1
|
1
|
0
|
| TRIM17
|
1
|
0
|
| THBS1
|
1
|
0
|
| ITFG1
|
1
|
0
|
| FXN
|
1
|
0
|
| DLL1
|
1
|
0
|
| HLA-DRB1
|
1
|
0
|
| LMNA
|
1
|
0
|
| MPZ
|
1
|
0
|
| TGFBR2
|
1
|
0
|
| ISPD
|
1
|
0
|
| ZNF9
|
1
|
0
|
| MYOZ3
|
1
|
0
|
| MFN2
|
1
|
0
|
| SLC25A4
|
1
|
0
|
| LDB3
|
1
|
0
|
| ZNF555
|
1
|
0
|
| DES
|
1
|
0
|
| CLCN1
|
1
|
0
|
| FCGR3A
|
1
|
0
|
| MMD
|
1
|
0
|
| GAA
|
1
|
1
|
| GMPPB
|
1
|
0
|
| NOS1
|
1
|
0
|
| CD40
|
1
|
0
|
| CKM
|
1
|
0
|
| LAMA2
|
1
|
0
|
| VCP
|
1
|
0
|
| KTN1
|
1
|
0
|
| MYH7
|
1
|
0
|
| MYOZ2
|
1
|
0
|
| COX8A
|
1
|
0
|
| ENO3
|
1
|
0
|
| PABPN1
|
1
|
0
|
| UTRN
|
1
|
0
|
| SGCZ
|
1
|
0
|
| FCGR3B
|
1
|
0
|
| PRPF6
|
1
|
0
|
| KCNN3
|
1
|
0
|
| HLA-A
|
1
|
0
|
| PMP22
|
1
|
0
|
| SGCB
|
1
|
0
|
|
Note: The number of publications displayed in this table will differ from the number displayed in the HuGE Literature Finder as the number
in Phenopedia reflects only the indexed disease term, but the number in the HuGE Literature Finder
reflects all text searches of the disease term including the indexed term.
|
|
|
